RIBOCYTOKINE
LIVE

Serial Number

79266179

Owner

BioNTech SE

Attorney

Monica Riva Talley

Filing Date

Apr 30, 2019

Add to watchlist:

No watchlists yet
View on USPTO

RIBOCYTOKINE Trademark

Serial Number: 79266179 • Registration: 6093112

RIBOCYTOKINE is a trademark filed by BioNTech SE on April 30, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

BioNTech SE (46 trademarks)

An der Goldgrube 12

Entity Type: 94

BIONTECH RNA PHARMACEUTICALS GMBH (12 trademarks)

AN DER GOLDGRUBE 12
55131 MAINZ 60430 , DE

Entity Type: 16

Trademark Details

Filing Date

April 30, 2019

Registration Date

July 7, 2020

Published for Opposition

April 21, 2020

Goods & Services

Treatment and conversion of material, namely, custom manufacturing of chemical and biochemical preparations; custom manufacturing of biopharmaceuticals, chemical agents for laboratory use, in particular nucleic acids, peptides and proteins, pharmaceutical products of all kinds, in particular for treating cancerous diseases, infections and autoimmune disorders, and of chemical agents for the production of anticancer drugs and vaccines, in particular nucleic acids, peptides and proteins; custom manufacturing of therapeutic pharmaceuticals

Pharmaceutical products for treating cancerous diseases, infections and autoimmune disorders

Chemical agents for laboratory use, in particular nucleic acids, peptides and proteins; chemical agents for the production of anticancer drugs and vaccines, in particular nucleic acids, peptides and proteins

Medical and veterinary services in connection with the treatment of cancerous diseases, infections and autoimmune disorders

Scientific research for medical purposes, in particular for developing treatment concepts for cancerous diseases, infections and autoimmune diseases

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 7, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jan 31, 2025 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 30, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 30, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 30, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 30, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 30, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 30, 2024 COAR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 19, 2021 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 10, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 30, 2020 FICS
FINAL DISPOSITION PROCESSED
Oct 29, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 7, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 7, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 21, 2020 NPUB
PUBLISHED FOR OPPOSITION
Apr 21, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 1, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 19, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 18, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 18, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 18, 2020 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Jan 16, 2020 NREP
REFUSAL PROCESSED BY IB
Oct 12, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 20, 2019 RFCS
REFUSAL PROCESSED BY MPU
Sep 20, 2019 RFRR
APPLICATION FILING RECEIPT MAILED
Sep 13, 2019 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 10, 2019 RFCR
NON-FINAL ACTION WRITTEN
Sep 9, 2019 CNRT
ASSIGNED TO EXAMINER
Sep 9, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 9, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 29, 2019 REPR